Pharmafile Logo

COUCH Medcomms

- PMLiVE

ICR and Merck renew strategic alliance for development of new cancer drugs

The latest agreement builds on 20 years of collaboration between the two partners

- PMLiVE

DeepMind’s AI tool classifies effects of mutations in genetic diseases

The Google unit's AlphaMissense tool has classified the effects of 71 million ‘missense’ mutations

- PMLiVE

CDC awards over $23m to Johns Hopkins Center for Health Security project

The five-year grant will be used to help launch a new epidemic preparedness project

Looking to start activity on a currently unpromoted pharmaceutical brand?

Looking to start activity on your current unpromoted brands in the UK? CHASE can fully manage the renewal of promotion! Get in touch with Richard Baderin on 0131 553 6644 or...

CHASE

https://youtu.be/866830208

Considering a portfolio review?

Are you considering a portfolio review for your established pharmaceutical brands? Wondering if you should put some activity behind them? At CHASE our experienced team will ensure you maximise your...

Wilmington Healthcare

Want the most from your Pharmaceutical portfolio?

Are you looking to maximise your mature pharmaceutical portfolio? With CHASE we can deliver innovative solutions to help your brands reach their potential! Get in touch with Richard Baderin on 0131...

CHASE

10 Important Advisor Questions: Placement of Your Product in the Current/Future Treatment Algorithm

As part of our top 10 most important advisor questions that every brand team should keep in mind when designing virtual advisory board touchpoints, here's another one to keep in...

Impetus Digital

- PMLiVE

Merck announces partnerships worth $1.3bn with BenevolentAI and Exscientia

The deals aim to accelerate drug development in oncology, neurology and immunology

EU flag

EC approves Menarini Group’s Orserdu for advanced or metastatic breast cancer

More than 550,000 people are diagnosed with breast cancer each year in Europe

- PMLiVE

Eli Lilly files US lawsuits over ‘unlawful’ sales of Mounjaro counterfeits

Lilly is the only FDA-approved company to legally sell products containing tirzepatide

- PMLiVE

Takeda announces CHMP recommendation for Adcetris in Hodgkin lymphoma

The ADC has been recommended with doxorubicin, vinblastine and dacarbazine

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links